Literature DB >> 23440406

The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients.

Xue-Fei Wang1, Ya-Kui Zhang, Zhen-Shan Yu, Jun-Lin Zhou.   

Abstract

Intertrochanteric fractures occur most commonly in elderly patients. Osteoblasts and osteoclasts have been reported to be regulated by the receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG), during bone modeling and remodeling, respectively. Based on these observations, we hypothesized that the serum levels of RANKL, OPG and the RANKL/OPG ratio are important in the healing of intertrochanteric fractures in elderly patients. Enzyme-linked immunosorbent assays were used to measure the serum concentrations of RANKL and OPG in 36 elderly patients with intertrochanteric fractures and 30 age-matched healthy control subjects, at baseline and 4, 8 and 12 weeks following injury. The RANKL/OPG ratio in the two groups was also evaluated. Similar trends in RANKL and OPG levels were detected during the fracture healing process. The serum levels of RANKL and OPG were higher in the fracture group than in the controls, and were significantly higher at baseline and 4 weeks following injury (P<0.05). Notably, although the RANKL/OPG ratio gradually increased during healing, it was lower in the fracture group than in the control group. The RANKL/OPG ratio was significantly lower immediately after and 4 weeks after injury in the fracture group (P<0.05). Our data suggest a close correlation between higher serum levels of RANKL and OPG and the fracture healing process, indicating that RANKL and OPG are involved in fracture healing. The serum RANKL/OPG ratio also appears to be significant in the healing of intertrochanteric fractures in elderly patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23440406     DOI: 10.3892/mmr.2013.1335

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

Review 1.  Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis.

Authors:  Yahui Grace Chiu; Christopher T Ritchlin
Journal:  Expert Opin Biol Ther       Date:  2016-11-30       Impact factor: 4.388

2.  Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.

Authors:  P Wanby; R Nobin; S-P Von; L Brudin; M Carlsson
Journal:  J Endocrinol Invest       Date:  2016-02-05       Impact factor: 4.256

Review 3.  [Progress of research on the relationship between calcitonin gene-related peptide and RANK/RANKL/OPG system in the bone reconstruction].

Authors:  Shiyao Wang; Shaoce Xu; Zhengwei Shi; Jianchao Wu; Shuanhu Lei; Yuliang Wang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-04-15

4.  RANKL immunisation inhibits prostate cancer metastasis by modulating EMT through a RANKL-dependent pathway.

Authors:  Mineon Park; Yong Jin Cho; Bora Kim; Young Jong Ko; Yuria Jang; Yeon Hee Moon; Hoon Hyun; Wonbong Lim
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

5.  Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach.

Authors:  Donatella Granchi; Enrique Gómez-Barrena; Markus Rojewski; Philippe Rosset; Pierre Layrolle; Benedetta Spazzoli; Davide Maria Donati; Gabriela Ciapetti
Journal:  Stem Cells Int       Date:  2017-06-20       Impact factor: 5.443

6.  TGF-β and Physiological Root Resorption of Deciduous Teeth.

Authors:  Emi Shimazaki; Takeo Karakida; Ryuji Yamamoto; Saeko Kobayashi; Makoto Fukae; Yasuo Yamakoshi; Yoshinobu Asada
Journal:  Int J Mol Sci       Date:  2016-12-27       Impact factor: 5.923

7.  Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts.

Authors:  Do-Won Lee; Jae-Young Kwon; Hae-Kyu Kim; Hyeon-Jeong Lee; Eun-Soo Kim; Hyae-Jin Kim; Hyung-Joon Kim; Han-Bit Lee
Journal:  Int J Med Sci       Date:  2018-05-14       Impact factor: 3.738

8.  Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer.

Authors:  Yun Ye; Su-Liang Li; Yue-Yun Ma; Yan-Jun Diao; Liu Yang; Ming-Quan Su; Zhuo Li; Yang Ji; Juan Wang; Lin Lei; Wei-Xiao Fan; La-Xiu Li; Yi Xu; Xiao-Ke Hao
Journal:  Oncotarget       Date:  2017-10-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.